...
首页> 外文期刊>Drug metabolism letters >Strong Induction of Cytochrome P450 1A/3A, But not P450 2B, in Cultured Hepatocytes from Common Marmosets and Cynomolgus Monkeys by Typical Human P450 Inducing Agents
【24h】

Strong Induction of Cytochrome P450 1A/3A, But not P450 2B, in Cultured Hepatocytes from Common Marmosets and Cynomolgus Monkeys by Typical Human P450 Inducing Agents

机译:通过典型的人P450诱导剂,强烈诱导细胞色素P450 1A / 3A,但不是P450 2B,来自普通Marmosets和Cynomolgus猴的培养肝细胞中的肝细胞

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Common marmosets (Callithrix jacchus) and cynomolgus monkeys (Macaca fascicularis) are used as non-human primate models in preclinical studies for drug development. Objective: The assessment of P450 induction in hepatocytes from marmosets and cynomolgus monkeys was performed using typical P450 inducers. Methods: Induction of cytochrome P450 1-4 family enzymes was analyzed in two lots of cultured hepatocytes from common marmosets and cynomolgus monkeys after 24-h treatment with typical human P450 inducing agents by real-time reverse transcription-polymerase chain reaction. Results: Marmoset P450 3A4 mRNA and P450 2C8/2C19 mRNA in hepatocytes were strongly (>10-fold) and weakly (>2) induced by rifampicin, respectively. Marmoset 1A1 and 1A2 mRNA were induced strongly (>200-fold) by P-naphthofiavone and omeprazole. Marmoset P450 2B6 mRNA was induced (~5-fold) by a constitutive androstane receptor agonist, but not by phenobarbital. Cynomolgus monkey P450 3A4 mRNA and P450 1A1 mRNA in cultured hepatocytes were also induced by rifampicin and omeprazole, respectively, but P450 2B6 mRNA was not induced by phenobarbital. Conclusion: These results indicate that P450 1A/3A induction by typical human P450 inducers in hepatocytes from marmosets and/or cynomolgus monkeys are similar to those of humans (except for P450 2B induction by phenobarbital in humans), suggesting that marmosets and cynomolgus monkeys might be suitable models for evaluating the drug interactions in preclinical studies.
机译:背景:常见的Marmosets(Callithrix Jacchus)和Cynomolgus猴(Macaca Fascicularis)用作药物开发的临床前研究中的非人灵长类动物模型。目的:使用典型的P450诱导剂进行来自Marmosets和Cynomolgus猴的肝细胞中P450诱导的评估。方法:通过实时逆转录 - 聚合酶链反应在24-H处理后,分析了在两批来自常见的Mararmosets和Cynomolgus猴的两种培养的肝细胞中进行细胞色素P450 1-4家族酶的诱导。结果:Marmoset P450 3A4 mRNA和P450 2C8 / 2C19分别肝细胞中的mRNA,分别由利福平诱导的强烈(> 10倍)和弱(> 2)。通过P-Naphthofia Vone和奥美拉唑强烈地(> 200倍)诱导Marmoset 1A1和1A2 mRNA。 Marmoset P450 2b6 mRNA通过组成型和解烷受体激动剂诱导(〜5倍),但不是苯巴比妥。 CynoMolgus monkey p450 3a4 mRNA和p450 1a1 mRNA分别由利福平和奥美拉唑诱导培养的肝细胞中,但P450 2b6 mRNA未被苯巴比妥诱导。结论:这些结果表明,来自Mararosets和/或鱼糜猴的肝细胞中典型人P450诱导剂的P450 1A / 3A诱导与人类的肝癌相似(除了人类苯巴比巴的P450 2B诱导),表明Marmosets和Cynomolgus猴子可能是评估临床前研究中药物相互作用的合适模型。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号